Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Sell
7,500
-100
-1% -$34.2K 0.01% 506
2026
Q1
$2.67M Hold
7,600
0.01% 463
2025
Q4
$2.49M Sell
7,600
-100
-1% -$31.7K 0.01% 483
2025
Q3
$2.17M Buy
7,700
+200
+3% +$58K 0.01% 507
2025
Q2
$2.09M Buy
7,500
+100
+1% +$28.3K 0.01% 502
2025
Q1
$2.31M Hold
7,400
0.01% 456
2024
Q4
$1.93M Hold
7,400
0.01% 487
2024
Q3
$2.38M Hold
7,400
0.01% 438
2024
Q2
$2.31M Buy
7,400
+200
+3% +$58.8K 0.01% 427
2024
Q1
$2.05M Hold
7,200
0.01% 447
2023
Q4
$2.07M Buy
7,200
+200
+3% +$54.5K 0.01% 407
2023
Q3
$1.88M Buy
7,000
+100
+1% +$25K 0.01% 391
2023
Q2
$1.53M Buy
6,900
+100
+1% +$23.2K 0.01% 439
2023
Q1
$1.64M Buy
6,800
+100
+1% +$24.5K 0.01% 412
2022
Q4
$1.76M Buy
6,700
+100
+2% +$26.8K 0.01% 386
2022
Q3
$1.49M Buy
6,600
+100
+2% +$24.2K 0.01% 403
2022
Q2
$1.58M Buy
6,500
+100
+2% +$24.5K 0.01% 409
2022
Q1
$1.55M Buy
6,400
+300
+5% +$68.9K 0.01% 447
2021
Q4
$1.37M Buy
+6,100
New +$1.29M 0.01% 491

Other funds holding AMGN

Davenport & Co's AMGN Position: Q2 2026 in Review

Davenport & Co reduced its Amgen (AMGN) stake by 0.75% in Q2 2026, selling an estimated $149K and leaving 57,790 shares worth $20.9M. The position accounts for 0.1% of the portfolio, ranked #169.

Davenport & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $44.2M in Q3 2014. 851 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Davenport & Co held 57,790 shares of Amgen worth $20.9M as of Q2 2026.
  • Davenport & Co sold 436 Amgen shares in Q2 2026, an estimated $149K.
  • Amgen made up 0.1% of Davenport & Co's portfolio in Q2 2026, its #169 holding.
  • Davenport & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Amgen position peaked at $44.2M in Q3 2014.
  • 851 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.